Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans

Tongzhi Wu, Beiyi R. Zhao, Michelle J. Bound, +7

American Journal of Clinical Nutrition

ObesityNutritionDifferent Sweet PreloadsAppetite ControlPhysiology +8

Effects of rectal administration of taurocholic acid on glucagon‐like peptide‐1 and peptide <scp>YY</scp> secretion in healthy humans

Tongzhi Wu, Michelle J. Bound, Scott Standfield, +4

Diabetes Obesity and Metabolism

Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial

Sony S. Thazhath, Tongzhi Wu, Michelle J. Bound, +5

American Journal of Clinical Nutrition

Metabolic SyndromeDiabetes ManagementGlucagon-like Peptide 1MedicinePhysiology +7

Disordered Control of Intestinal Sweet Taste Receptor Expression and Glucose Absorption in Type 2 Diabetes

Richard L. Young, Bridgette Chia, Nicole J. Isaacs, +5

Diabetes

Glucose AbsorptionHealthy SubjectsGastroenterologyInsulin SignalingGastrointestinal Peptide Hormone +16

A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes

Tongzhi Wu, Tanya J. Little, Michelle J. Bound, +6

Diabetes Care

Gastric Emptying in Patients With Well-Controlled Type 2 Diabetes Compared With Young and Older Control Subjects Without Diabetes

Linda E. Watson, Cong Xie, Xuyi Wang, +6

The Journal of Clinical Endocrinology & Metabolism

Muscle strength and prediabetes progression and regression in middle‐aged and older adults: a prospective cohort study

Shanhu Qiu, Xue Cai, Yang Yuan, +4

Journal of Cachexia Sarcopenia and Muscle

Effects of Taurocholic Acid on Glycemic, Glucagon-like Peptide-1, and Insulin Responses to Small Intestinal Glucose Infusion in Healthy Humans

Tongzhi Wu, Michelle J. Bound, Scott Standfield, +3

The Journal of Clinical Endocrinology & Metabolism

Augmented capacity for peripheral serotonin release in human obesity

Richard L. Young, Amanda L. Lumsden, Alyce M. Martin, +18

International Journal of Obesity

ObesityMetabolic SyndromeEnergy HomeostasisBody CompositionPhysiology +5

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial

Sony S. Thazhath, Chinmay S. Marathe, Tongzhi Wu, +10

Diabetes

Healthy SubjectsGastrointestinal PharmacologyGastroenterologyGastrointestinal Peptide HormoneMetabolic Syndrome +15